BIOAF (Bioasis Technologies) EBITDA Margin %: -494.59% (As of Nov. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOAF Bioasis Technologies Inc BIOAF
12 GF Score
Price $0.00
View Full Analysis

What is Bioasis Technologies EBITDA Margin %?

Bioasis Technologies BIOAF 12 EBITDA Margin % is -494.59% as of Nov. 2022. GuruFocus rates BIOAF with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bioasis Technologies's EBITDA for the three months ended in Nov. 2022 was $-0.55 Mil. Bioasis Technologies's Revenue for the three months ended in Nov. 2022 was $0.11 Mil. Therefore, Bioasis Technologies's EBITDA margin for the quarter that ended in Nov. 2022 was -494.59%.

Bioasis Technologies  (OTCPK:BIOAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Bioasis Technologies EBITDA Margin % Related Terms

Bioasis Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Bioasis Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies EBITDA Margin % Chart

Bioasis Technologies Annual Data
Trend Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -883.80 -336.40 -747.81 10.80 -9,290.00

Bioasis Technologies Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,693.33 0.00 0.00 -690.32 -494.59

BIOAF vs VRTX, REGN, SGEN: EBITDA Margin % Comparison

For the Biotechnology subindustry, Bioasis Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's EBITDA Margin % falls into.


BIOAF
12GF Score
Bioasis Technologies Inc BIOAF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioasis Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bioasis Technologies's EBITDA Margin % for the fiscal year that ended in Feb. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Feb. 2022 )/Revenue (A: Feb. 2022 )
=-2.787/0.03
=-9,290.00 %

Bioasis Technologies's EBITDA Margin % for the quarter that ended in Nov. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Nov. 2022 )/Revenue (Q: Nov. 2022 )
=-0.549/0.111
=-494.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -494.59% mean?
Bioasis Technologies (BIOAF) has a EBITDA Margin % of -494.59% as of Nov. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bioasis Technologies and its competitors.
Is Bioasis Technologies' EBITDA Margin % too high?
Bioasis Technologies' current EBITDA Margin % is -494.59%. Overall, Bioasis Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioasis Technologies' EBITDA Margin % compare to VRTX and REGN?
Bioasis Technologies' EBITDA Margin % of -494.59% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bioasis Technologies and its competitors. Bioasis Technologies's current EBITDA Margin % is -494.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioasis Technologies stock overvalued right now?
Bioasis Technologies (BIOAF) has a current EBITDA Margin % of -494.59%. The current EBITDA Margin % is -494.59%. Bioasis Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bioasis Technologies (BIOAF), the current EBITDA Margin % is -494.59% as of Nov. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioasis Technologies Business Description

Address 157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB).
12GF Score

Get the complete analysis for BIOAF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price